Results 291 to 300 of about 655,517 (311)

HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide

Biology of Blood and Marrow Transplantation, 2020
Mónica Thakar, Hans-Peter Kiem, Haydar Frangoul   +2 more
exaly  

Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

Blood, 2010
Gérard Socie, Vanderson Rocha
exaly  

Transplant Pharmacology and Conditioning Therapy

2020
openaire   +1 more source

Pharmacology of Bone Marrow Transplantation Conditioning Regimensa

Annals of the New York Academy of Sciences, 1995
R J, Jones, L B, Grochow
openaire   +2 more sources

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

Biology of Blood and Marrow Transplantation, 2008
Robert Brodsky, William Matsui
exaly  

Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation, 2019
Mohamad Mohty, Giorgia Battipaglia, Florent Malard   +2 more
exaly  

Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders

Molecular Therapy, 2006
Frédéric Baron, Rainer Storb
exaly  

Umbilical cord blood transplantation using non-myeloablative conditioning: The Mexican experience

Hematology, 2006
David Gomez-Almaguer, Oscar Gonzalez
exaly  

[Essential conditions for corneal transplantation].

Svenska lakartidningen, 2000
C H, DOHLMAN, S, LARSSON
openaire   +1 more source

Improving the number and condition of donor lungs for transplantation*

Critical Care Medicine, 2005
openaire   +2 more sources